title: A cell model system to study regulation of phosphotidylinositol 3-kinase and protein kinase B activity by cytokines/growth factors produced by type I collagen stimulated immune cells from patients with systemic sclerosis.
abstract: We have reported that posttranslational modification of systemic sclerosis patients' platelet phosphoinositide 1,3,4,5 kinase (PI 3-K) and protein kinase B (Akt) altered their enzymatic activities. In the present investigation, we have established a cell line model to study further the effects of posttranslational modification and modification by cytokines or growth factors of these two enzymes. Results from these studies suggest that posttranslational modification by phosphorylation of Akt and nitrotyrosylation of PI 3-K increases enzymatic activities, as was observed from SSc patients' platelets. These two signaling components are controlled by a different mechanism, which alters platelet reactivity towards the matrix components of vascular walls. We have used a megakaryotic cell line to study these two enzymes in the presence of cultured supernatants from peripheral blood mononuclear cells (PBMC), which were isolated from blood of SSc patients compared to controls including culture medium, rheumatoid arthritis, systemic lupus erythematosus, and osteoarthritis. The effect of the supernatants from SSc CI-stimulated PBMC cultures on both PI 3-K and Akt is specific.
authors.affiliation: Veterans Affairs Medical Center, 1030 Jefferson Avenue, Memphis, TN 38104, USA. tchiang@utmem.edu
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Chiang
authors.forename: Arnold E
authors.initials: AE
authors.lastname: Postlethwaite
mesh_terms: D001172:Arthritis, Rheumatoid / Q000097:blood; D016022:Case-Control Studies; D002460:Cell Line; D002478:Cells, Cultured; D024042:Collagen Type I / Q000494:pharmacology*; D003470:Culture Media / Q000378:metabolism; D016207:Cytokines / Q000494:pharmacology*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology*; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000097:blood; D008533:Megakaryocytes / Q000166:cytology* / Q000201:enzymology; D019001:Nitric Oxide Synthase / Q000378:metabolism; D010003:Osteoarthritis / Q000097:blood; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D012595:Scleroderma, Systemic / Q000378:metabolism* / Q000473:pathology; D014443:Tyrosine / Q000031:analogs & derivatives / Q000378:metabolism
chemical_list: D024042:Collagen Type I; D003470:Culture Media; D016207:Cytokines; D036341:Intercellular Signaling Peptides and Proteins; D014443:Tyrosine; D019001:Nitric Oxide Synthase; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt